Dupilumab for atopic dermatitis treatment: A single-center retrospective study
Background and Design: Atopic dermatitis (AD) is a common chronic, recurrent, and itchy inflammatory skin disease. Various therapeutic agents are available, but severe side effects may limit their usage. Recently, dupilumab, a human monoclonal antibody that targets the interleukin-4 (IL-4) receptor...
Spremljeno u:
| Glavni autori: | , , |
|---|---|
| Format: | Artigo |
| Jezik: | Inglês |
| Izdano: |
Society of Dermatology and Venereology
2022-03-01
|
| Serija: | Turkderm Turkish Archives of Dermatology and Venereology |
| Teme: | |
| Online pristup: | https://journal.turkderm.org.tr/jvi.aspx?pdir=turkderm&plng=eng&un=TURKDERM-36604&look4= |
| Oznake: |
Bez oznaka, Budi prvi tko označuje ovaj zapis!
|